elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
Pricing
Log in
Sign up
Home
/
Subjects
/
Neuromyelitis optica
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Neuromyelitis optica
RIS
0.001
(Research Intensity Score)
Papers
67
Top papers
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT
2025 · 58 citations
The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function
2025 · 26 citations
The role of Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: Advancing clinical applications.
2025 · 20 citations
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature
2018 · 217 citations
Neurodegenerative Biomarkers in Multiple Sclerosis: At the Interface Between Research and Clinical Practice
2025 · 13 citations
2.5D transfer deep learning model for segmentation of contrast-enhancing lesions on brain magnetic resonance imaging of multiple sclerosis and neuromyelitis optica spectrum disorder
2024 · 17 citations
Glial Fibrillary Acidic Protein Astrocytopathy Based on a Two‐Center Chinese Cohort Study
2025 · 8 citations
Dual BLyS/APRIL targeted therapy with telitacicept in rituximab-refractory SLE-associated neuromyelitis optica spectrum disorder: a case report
2025 · 8 citations
Advances in biomarkers for optic neuritis and neuromyelitis optica spectrum disorders: a multi-omics perspective
2025 · 8 citations
Newest papers
The Crossroads of Neuroinflammation and Biomarkers in Multiple Sclerosis: A Systematic Review
2026 · 2 citations
Intractable hiccups as a brainstem red flag: demyelinating disorders with emphasis on neuromyelitis optica spectrum disorder and area postrema syndrome
2026
Optic Neuritis in a Patient with Morning Glory Syndrome: A Case Report
2026
Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial
2026
Neuromyelitis Optica Spectrum Disorder: A Clinical Review
2026
Apparent per-session removal of AQP4-IgG during therapeutic plasma exchange in a patient with aquaporin-4 antibody–positive neuromyelitis optica spectrum disorders: a case report
2026
AQP4-IgG Dynamics and Exploratory Assessment of SERA-3 in Neuromyelitis Optica Spectrum Disorder Treated with Satralizumab
2026
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT
2025 · 58 citations
The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function
2025 · 26 citations
Browse all papers →
Neuromyelitis optica's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Neuromyelitis optica's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link